Serum or cerebrospinal fluid levels of glyceraldehyde-derived advanced glycation end products (AGEs) may be a promising biomarker for early detection of Alzheimer's disease (Q46432570)
scientific article published in January 2005
Language:
(P31) (Q13442814)
(P304) 1205-1207
(P433) 6
(P478) 64
(P577) Saturday, January 1, 2005
(P921) (Q11081)
(Q54196)
(Q864574)
(P1433) (Q5558534)
(P1476) "Serum or cerebrospinal fluid levels of glyceraldehyde-derived advanced glycation end products (AGEs) may be a promising biomarker for early detection of Alzheimer's disease" (language: en)
(P2093) Yamagishi S
Nakamura K
Inoue H
Kikuchi S
Takeuchi M
other details
description scientific article published in January 2005

External Links